• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者和持续性非卧床腹膜透析患者对其处方药的了解情况。

Knowledge of hemodialysis and CAPD patients about their prescribed medicines.

作者信息

Blanchard R, Berger W, Bailie G R, Eisele G

机构信息

Department of Pharmacy Practice, Albany College of Pharmacy, NY 12208.

出版信息

Clin Nephrol. 1990 Oct;34(4):173-8.

PMID:2257703
Abstract

A questionnaire was designed to determine and compare the extent of knowledge of 40 continuous ambulatory peritoneal dialysis (CAPD) and 40 hemodialysis (HD) patients about their medicines. It was administered orally to outpatients attending a clinic by an investigator unknown to the patients. Data were collected pertaining to the following target drugs: calcium supplements, phosphate binders, vitamins B and C and folic acid. HD and CAPD groups were closely matched for age and sex. Sixty percent of CAPD and 49% of HD patients were taking four or more medications. The dose of folic acid was accurately recalled by 91% and 71% of CAPD and HD patients. Indications for calcium supplements and phosphate binders were known by only 8% and 30% of CAPD patients compared to 72% and 73% of HD patients. More HD patients knew the indications for all target drugs (p less than 0.01). More CAPD than HD patients knew the expected duration of therapy (p less than 0.01). There was a trend between decreased knowledge of whether the medication was working with increasing age of CAPD patients. Most drug information was supplied by physicians, but many CAPD patients (21%) obtained information from lay sources. When given the opportunity to ask questions about their medicines, only 56% CAPD and 46% HD patients did so. The knowledge of CAPD and HD patients studied was grossly deficient in terms of indications, effectiveness, duration and action to be taken if doses were missed.

摘要

设计了一份问卷,以确定并比较40名持续性非卧床腹膜透析(CAPD)患者和40名血液透析(HD)患者对其所用药物的了解程度。该问卷由患者不认识的调查员对门诊患者进行口头询问。收集了以下目标药物的数据:钙补充剂、磷结合剂、维生素B、维生素C和叶酸。HD组和CAPD组在年龄和性别方面进行了严格匹配。60%的CAPD患者和49%的HD患者正在服用四种或更多药物。91%的CAPD患者和71%的HD患者能准确回忆起叶酸的剂量。与72%的HD患者和73%的HD患者相比,只有8%的CAPD患者知道钙补充剂的适应证,30%的CAPD患者知道磷结合剂的适应证。更多的HD患者知道所有目标药物的适应证(p<0.01)。知道治疗预期持续时间的CAPD患者比HD患者更多(p<0.01)。CAPD患者中,随着年龄增长,对药物是否有效的了解呈下降趋势。大多数药物信息由医生提供,但许多CAPD患者(21%)从非专业渠道获取信息。当有机会询问有关他们所用药物的问题时,只有56%的CAPD患者和46%的HD患者这样做了。就适应证、有效性、持续时间以及漏服剂量时应采取的措施而言,所研究的CAPD患者和HD患者的知识严重不足。

相似文献

1
Knowledge of hemodialysis and CAPD patients about their prescribed medicines.血液透析患者和持续性非卧床腹膜透析患者对其处方药的了解情况。
Clin Nephrol. 1990 Oct;34(4):173-8.
2
[Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].[持续性非卧床腹膜透析或维持性血液透析的慢性肾衰竭患者多发性神经病变严重程度的评估]
Przegl Lek. 2007;64(6):423-30.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
Health-related quality of life in patients on peritoneal dialysis in Serbia: comparison with hemodialysis.塞尔维亚腹膜透析患者的健康相关生活质量:与血液透析的比较。
Artif Organs. 2007 Dec;31(12):901-10. doi: 10.1111/j.1525-1594.2007.00483.x. Epub 2007 Oct 8.
5
Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.台湾接受血液透析和持续性非卧床腹膜透析患者的血浆游离氨基酸及其代谢产物
Clin Chim Acta. 2006 Feb;364(1-2):209-16. doi: 10.1016/j.cccn.2005.07.001. Epub 2005 Aug 8.
6
Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.
Adv Perit Dial. 2003;19:148-54.
7
The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.持续非卧床腹膜透析、血液透析及肾移植患者对流感疫苗抗体反应的比较。
Scand J Urol Nephrol. 2003;37(1):71-6. doi: 10.1080/00365590310008749.
8
Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.长期持续性非卧床腹膜透析患者与血液透析患者的超声心动图评估比较
Clin Nephrol. 1998 May;49(5):308-12.
9
Comparison of long-term survival between hemodialysis and peritoneal dialysis.血液透析与腹膜透析的长期生存率比较。
Adv Perit Dial. 1996;12:79-88.
10
[Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].终末期慢性肾衰竭患者中的丙型肝炎病毒。I. 患病率
Rev Invest Clin. 2000 May-Jun;52(3):246-54.

引用本文的文献

1
Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review.血液透析患者药物治疗的不依从性:一项系统评价
PLoS One. 2015 Dec 4;10(12):e0144119. doi: 10.1371/journal.pone.0144119. eCollection 2015.
2
Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS.磷结合剂药丸负担、患者报告的不依从性和矿物质骨病标志物:来自透析预后和实践模式研究(DOPPS)的结果
Hemodial Int. 2016 Jan;20(1):38-49. doi: 10.1111/hdi.12315. Epub 2015 May 14.
3
Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature.
成年慢性血液透析患者口服药物治疗的依从性:文献综述
Eur J Med Res. 2009 May 14;14(5):185-90. doi: 10.1186/2047-783x-14-5-185.
4
A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.终末期肾病患者中磷酸盐结合药物治疗依从性的患病率及决定因素的系统评价。
BMC Nephrol. 2008 Jan 31;9:2. doi: 10.1186/1471-2369-9-2.
5
Hyperphosphatemia in children receiving peritoneal dialysis--an educational program.
Pediatr Nephrol. 2005 Jul;20(7):967-71. doi: 10.1007/s00467-005-1884-y. Epub 2005 May 5.